Results 11 to 20 of about 9,162 (237)

Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs

open access: yesMolecules
The accumulation of senescent cells is a major contributor to aging and various age-related diseases, making developing senolytic compounds that are capable of clearing these cells an important area of research. However, progress has been hampered by the
Jinjun Li   +9 more
doaj   +2 more sources

A pipeline for senolytics

open access: yesThe Journal of Clinical Investigation
There is intense interest in identifying compounds that selectively kill senescent cells, termed senolytics, for ameliorating age-related comorbidities.
Sundeep Khosla
doaj   +3 more sources

Cardiac Glycosides as Senolytic Compounds [PDF]

open access: yesTrends in Molecular Medicine, 2020
The identification of senolytics, compounds that eliminate senescent cells, is presently a key priority given their therapeutic promise in cancer and aging-associated diseases. Two recent papers by Triana-Martínez et al. and Guerrero et al. report the senolytic activity of cardiac glycosides (CGs) and their efficacy in these pathophysiological contexts.
Martin, Nadine   +2 more
openaire   +2 more sources

Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Intervertebral disc degeneration (IVDD) is the main cause of cervical and lumbar spondylosis. Over the past few years, the relevance between cellular senescence and IVDD has been widely studied, and the senescence-associated secretory phenotype (SASP ...
Yuhao Wu   +16 more
doaj   +1 more source

Strategies for senolytic drug discovery

open access: yesAging Cell, 2023
AbstractSenolytics are a category of drugs that reduce the impact of cellular senescence, an effect associated with a range of chronic and age‐related diseases. Since the discovery of the first senolytics in 2015, the number of known senolytic agents has grown dramatically.
Helen Power   +3 more
openaire   +2 more sources

Evaluating the neuroprotective impact of senolytic drugs on human vision

open access: yesScientific Reports, 2020
Glaucoma, a chronic neurodegenerative disease of retinal ganglion cells (RGCs), is a leading cause of irreversible blindness worldwide. Its management currently focuses on lowering intraocular pressure to slow disease progression.
Nevin W. El-Nimri   +6 more
doaj   +1 more source

Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: Following an acute coronary syndrome, patients display an elevated inflammatory profile, promoted in part by cellular senescence. For patients requiring a coronary artery bypass (CABG) surgery, exposure to the surgical intervention and ...
Olina Dagher   +12 more
doaj   +1 more source

Senotherapeutics in Cancer and HIV

open access: yesCells, 2022
Cellular senescence is a stress-response mechanism that contributes to homeostasis maintenance, playing a beneficial role during embryogenesis and in normal adult organisms.
Laura Sánchez-Díaz   +3 more
doaj   +1 more source

Galactose‐modified duocarmycin prodrugs as senolytics [PDF]

open access: yesAging Cell, 2019
Abstract Senescence is a stable growth arrest that impairs the replication of damaged, old or preneoplastic cells, therefore contributing to tissue homeostasis. Senescent cells accumulate during ageing and are associated with cancer, fibrosis and many age‐related pathologies.
Guerrero, Ana   +7 more
openaire   +7 more sources

Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction

open access: yesMolecular Oncology, 2020
Tumor cells undergo senescence in response to both conventional and targeted cancer therapies. The induction of senescence in response to cancer therapy can contribute to unfavorable patient outcomes, potentially including disease relapse.
Tareq Saleh   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy